Medication info
Pidogrel Tablet 75 mg (Clopidogrel Bisulfate)

Pidogrel Tablet 75 mg (Clopidogrel Bisulfate)

Prescription medicationTabletOral
Ingredient · strength
Clopidogrel Bisulfate›97.875mg / 1 tablet
Manufacturer / importer
Widers Pharmaceutical Co., Ltd.
Appearance
Pink circular film-coated tablet
Packaging
30 tablets/bottle, 300 tablets/bottle
Approval status
Active

MFDS item code 201310896 · Approved 2013.12.26 · Insurance code 660702620

Summary

Main use
Improvement of symptoms of atherosclerosis and acute coronary syndrome; prevention of thromboembolism in atrial fibrillation
Who takes it
Adults
Adult dose
○ Adults 1. Patients with ischemic stroke, myocardial infarction, or peripheral arterial disease: Administer clopidogrel 75 mg orally once daily. 2. Patients with acute coronary syndrome (unstable angina or non-Q-wave myocardial infarction): On the day treatment with this drug is initiated, start with a loading dose of 300 mg once daily, followed by a maintenance dose of 75 mg once daily orally. Aspirin 75 ∼ 325 mg should be administered concomitantly with this drug once daily. 3. Patients with atrial fibrillation: Administer this drug 75 mg orally once daily. Aspirin 75 ∼ 100 mg should be administered concomitantly with this drug once daily. ○ Patients with renal impairment: Treatment experience in patients with renal impairment is limited. ○ Patients with hepatic impairment: Treatment experience in patients with moderate hepatic disease with a bleeding diathesis is limited. This drug may be administered with or without food.

Ingredients

Manufacturer
Widers Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of symptoms of atherosclerosis and acute coronary syndrome; prevention of thromboembolism in atrial fibrillation

  • Ischemic stroke
  • myocardial infarction
  • peripheral arterial disease
  • acute coronary syndrome
  • unstable angina
  • non-Q wave myocardial infarction
  • cardiovascular abnormalities
  • stroke
  • refractory ischemia
  • vascular risk factors
  • atrial fibrillation.
View approved original text

This medication is used to improve atherosclerosis-related symptoms in adult patients with ischemic stroke, myocardial infarction, or peripheral artery disease. It also helps alleviate cardiovascular abnormalities that may occur after drug treatment or coronary interventions, such as in patients with acute coronary syndrome, specifically unstable angina or non-Q wave myocardial infarction. Lastly, it plays a role in reducing the risk of stroke and thromboembolism in patients with atrial fibrillation who cannot take vitamin K antagonists. This medication is safe for patients with vascular risk factors and a low risk of bleeding, improving overall cardiovascular health.

How to take

Adult dose

○ Adults 1. Patients with ischemic stroke, myocardial infarction, or peripheral arterial disease: Administer clopidogrel 75 mg orally once daily. 2. Patients with acute coronary syndrome (unstable angina or non-Q-wave myocardial infarction): On the day treatment with this drug is initiated, start with a loading dose of 300 mg once daily, followed by a maintenance dose of 75 mg once daily orally. Aspirin 75 ∼ 325 mg should be administered concomitantly with this drug once daily. 3. Patients with atrial fibrillation: Administer this drug 75 mg orally once daily. Aspirin 75 ∼ 100 mg should be administered concomitantly with this drug once daily. ○ Patients with renal impairment: Treatment experience in patients with renal impairment is limited. ○ Patients with hepatic impairment: Treatment experience in patients with moderate hepatic disease with a bleeding diathesis is limited. This drug may be administered with or without food.

Precautions

This medication is used to inhibit the aggregation of platelets in the blood to prevent the formation of clots, thereby preventing cardiovascular diseases such as myocardial infarction and stroke. This drug is converted into its active form by the enzyme CYP2C19 in the liver, and if the function of this enzyme is genetically diminished, the efficacy may decrease, necessitating a reevaluation of the treatment regimen. Additionally, co-administration with drugs that activate the CYP2C19 enzyme may increase the concentration of the active ingredient of this drug, raising the risk of bleeding, so combinations should be avoided. Patients with allergies to this drug or its components, those with bleeding disorders, severe liver damage, or nursing mothers should not take this medication. Patients with a high risk of bleeding, liver disease, kidney impairment, acute stroke, high blood pressure, the elderly, underweight patients, and those with hypersensitivity to thienopyridines should be treated cautiously. Especially if bleeding symptoms are suspected, appropriate testing including blood tests should be performed immediately, and in the case of scheduled surgeries, this medication should be discontinued 5-7 days prior and restarted only after hemostasis is achieved. This medication can cause side effects such as bleeding, thrombocytopenia, gastrointestinal symptoms (abdominal pain, dyspepsia, diarrhea), skin rash, headache, dizziness, abdominal pain, nausea, hypercholesterolemia, arthralgia, low back pain, purpura, epistaxis, depression, upper respiratory infections, rhinitis, bronchitis, cough, rash, pruritus, urinary tract infections, chest pain, weight loss, weight gain, facial flushing, fatigue, rigidity, facial swelling, fainting, constipation, vomiting, ulcer, appetite loss. Rarely, serious hematological adverse reactions due to thrombocytopenia or acquired hemophilia may occur, so if any abnormal symptoms arise, medical attention should be sought immediately. While taking this medication, the risk of bleeding may increase, and caution is required when used in conjunction with other drugs that affect blood coagulation (such as aspirin, warfarin, NSAIDs, SSRIs, etc.). During pregnancy, the effects on the fetus are unclear, so it should only be used when severe cardiovascular conditions require treatment, and it is advisable to discontinue before labor to reduce the risk of bleeding. In breastfeeding cases, because this medication may be secreted in breast milk, a choice should be made to either stop breastfeeding or discontinue the medication. Safety and effectiveness in pediatric patients have not been established, and elderly patients may face an increased risk of bleeding due to decreased kidney and liver function, so they should be treated cautiously. In cases of overdose, bleeding time may be prolonged, and since there is no specific antidote, treatments such as platelet transfusion may be necessary if bleeding is severe. This medication should be kept out of reach of children, and transferring it to other containers should be avoided.

Side effects

  • Hemorrhage
  • gastrointestinal hemorrhage
  • purpura
  • contusion
  • hematoma
  • epistaxis
  • hematoma
  • hematuria
  • intraocular hemorrhage
  • intracranial hemorrhage
Show 116 more
  • severe neutropenia
  • aplastic anemia
  • thrombocytopenia
  • gastrointestinal symptoms
  • abdominal pain
  • dyspepsia
  • gastroenteritis
  • constipation
  • diarrhea
  • rash
  • skin adverse reactions
  • pruritus
  • depression
  • upper respiratory tract infection
  • dyspnea
  • rhinitis
  • bronchitis
  • cough
  • urinary tract infection
  • chest pain
  • accidental injury
  • influenza-like illness
  • pain
  • fatigue
  • edema
  • hypertension
  • headache
  • dizziness
  • nausea
  • hypercholesterolemia
  • arthralgia
  • low back pain
  • depression
  • insomnia
  • thrombocytopenia
  • anemia
  • bloody stools
  • hematoma
  • hematuria
  • hemoptysis
  • muscle hemorrhage
  • gingival hemorrhage
  • pulmonary hemorrhage
  • visual disturbances
  • visual field defects
  • dry eyes
  • transient blindness
  • congestion
  • tinnitus
  • taste disturbances
  • taste loss
  • vasculitis
  • hypotension
  • bronchospasm
  • interstitial pneumonia
  • eosinophilic pneumonia
  • colitis
  • pancreatitis
  • gastritis
  • stomatitis
  • hepatitis
  • acute liver failure
  • maculopapular rash
  • erythematous skin rash
  • urticaria
  • angioedema
  • vesicular dermatitis
  • drug-induced hypersensitivity syndrome
  • eczema
  • lichen planus
  • arthritis
  • myalgia
  • glomerulonephritis
  • gynecomastia
  • fever
  • abnormal liver function tests
  • hypochromic anemia
  • leukemia
  • leukopenia
  • eosinophilia
  • confusion
  • hallucinations
  • taste disturbances
  • taste loss
  • vasculitis
  • hypotension
  • bronchospasm
  • interstitial pneumonia
  • eosinophilic pneumonia
  • colitis
  • pancreatitis
  • gastritis
  • stomatitis
  • hepatitis
  • acute liver failure
  • herpes zoster
  • erythematous rash
  • maculopapular rash
  • urticaria
  • pruritus
  • angioedema
  • vesicular dermatitis
  • drug rash
  • eczema
  • lichen planus
  • arthralgia
  • arthritis
  • myalgia
  • glomerulonephritis
  • gynecomastia
  • fever
  • abnormal liver function tests
  • increased blood creatinine
  • spinal hematoma
  • cholecystitis
  • hematemesis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is susceptible to effects from air or moisture, so it must be stored in a tightly closed container. It is recommended to store it at room temperature, between 1 degree and 30 degrees Celsius. This will help maintain the efficacy of the medication for a longer time.

Appearance and packaging

Appearance

Pink circular film-coated tablet

Package unit

30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.